Meiji Yasuda Life Insurance’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.49M | Hold |
5,068
| – | – | 0.09% | 52 |
|
|
2025
Q4 | $2.94M | Buy |
5,068
+54
| +1% | +$30.5K | 0.09% | 50 |
|
|
2025
Q3 | $2.43M | Sell |
5,014
-11
| -0.2% | -$5.12K | 0.07% | 57 |
|
|
2025
Q2 | $2.04M | Sell |
5,025
-9,693
| -66% | -$4.05M | 0.06% | 80 |
|
|
2025
Q1 | $7.32M | Buy |
14,718
+58
| +0.4% | +$31.4K | 0.15% | 57 |
|
|
2024
Q4 | $7.63M | Sell |
14,660
-1,185
| -7% | -$652K | 0.14% | 58 |
|
|
2024
Q3 | $9.8M | Buy |
15,845
+263
| +2% | +$156K | 0.18% | 50 |
|
|
2024
Q2 | $8.62M | Buy |
15,582
+186
| +1% | +$107K | 0.17% | 49 |
|
|
2024
Q1 | $8.95M | Buy |
15,396
+1,180
| +8% | +$662K | 0.19% | 42 |
|
|
2023
Q4 | $7.55M | Buy |
14,216
+2,255
| +19% | +$1.09M | 0.16% | 36 |
|
|
2023
Q3 | $6.05M | Buy |
11,961
+2,279
| +24% | +$1.21M | 0.16% | 35 |
|
|
2023
Q2 | $5.05M | Buy |
9,682
+125
| +1% | +$67.5K | 0.13% | 35 |
|
|
2023
Q1 | $5.51M | Buy |
9,557
+92
| +1% | +$51.9K | 0.11% | 29 |
|
|
2022
Q4 | $5.21M | Sell |
9,465
-26
| -0.3% | -$13.8K | 0.11% | 34 |
|
|
2022
Q3 | $4.81M | Buy |
9,491
+368
| +4% | +$206K | 0.11% | 30 |
|
|
2022
Q2 | $4.96M | Buy |
9,123
+1,901
| +26% | +$1.05M | 0.08% | 27 |
|
|
2022
Q1 | $4.27M | Sell |
7,222
-153
| -2% | -$87.9K | 0.07% | 32 |
|
|
2021
Q4 | $4.92M | Sell |
7,375
-875
| -11% | -$546K | 0.09% | 24 |
|
|
2021
Q3 | $4.71M | Sell |
8,250
-31
| -0.4% | -$17K | 0.08% | 25 |
|
|
2021
Q2 | $4.18M | Sell |
8,281
-95
| -1% | -$44.8K | 0.08% | 28 |
|
|
2021
Q1 | $3.82M | Sell |
8,376
-1,214
| -13% | -$579K | 0.07% | 26 |
|
|
2020
Q4 | $4.47M | Sell |
9,590
-3,615
| -27% | -$1.69M | 0.08% | 24 |
|
|
2020
Q3 | $5.83M | Buy |
13,205
+439
| +3% | +$181K | 0.12% | 19 |
|
|
2020
Q2 | $4.63M | Buy |
12,766
+437
| +4% | +$146K | 0.18% | 24 |
|
|
2020
Q1 | $3.5M | Sell |
12,329
-791
| -6% | -$249K | 0.7% | 23 |
|
|
2019
Q4 | $4.26M | Sell |
13,120
-1,333
| -9% | -$404K | 0.58% | 30 |
|
|
2019
Q3 | $4.21M | Sell |
14,453
-193
| -1% | -$55.3K | 0.6% | 32 |
|
|
2019
Q2 | $4.3M | Sell |
14,646
-271
| -2% | -$74.6K | 0.63% | 29 |
|
|
2019
Q1 | $4.08M | Sell |
14,917
-2,350
| -14% | -$585K | 0.62% | 28 |
|
|
2018
Q4 | $3.86M | Sell |
17,267
-1,054
| -6% | -$247K | 0.6% | 33 |
|
|
2018
Q3 | $4.47M | Sell |
18,321
-400
| -2% | -$92K | 0.56% | 32 |
|
|
2018
Q2 | $3.88M | Sell |
18,721
-170
| -0.9% | -$36.1K | 0.53% | 33 |
|
|
2018
Q1 | $3.9M | Sell |
18,891
-2,470
| -12% | -$518K | 0.6% | 28 |
|
|
2017
Q4 | $4.06M | Sell |
21,361
-3,295
| -13% | -$631K | 0.56% | 31 |
|
|
2017
Q3 | $4.67M | Buy |
24,656
+1,400
| +6% | +$254K | 0.69% | 24 |
|
|
2017
Q2 | $4.06M | Buy |
23,256
+100
| +0.4% | +$16.8K | 0.62% | 26 |
|
|
2017
Q1 | $3.56M | Buy |
23,156
+7,340
| +46% | +$1.12M | 0.56% | 31 |
|
|
2016
Q4 | $2.23M | Sell |
15,816
-670
| -4% | -$98.8K | 0.37% | 61 |
|
|
2016
Q3 | $2.62M | Sell |
16,486
-1,850
| -10% | -$285K | 0.35% | 74 |
|
|
2016
Q2 | $2.71M | Sell |
18,336
-260
| -1% | -$38.4K | 0.43% | 57 |
|
|
2016
Q1 | $2.63M | Sell |
18,596
-400
| -2% | -$53.6K | 0.42% | 64 |
|
|
2015
Q4 | $2.69M | Buy |
18,996
+600
| +3% | +$80K | 0.43% | 63 |
|
|
2015
Q3 | $2.25M | Hold |
18,396
| – | – | 0.38% | 70 |
|
|
2015
Q2 | $2.39M | Buy |
18,396
+2,070
| +13% | +$270K | 0.37% | 73 |
|
|
2015
Q1 | $2.19M | Buy |
16,326
+2,166
| +15% | +$279K | 0.34% | 79 |
|
|
2014
Q4 | $1.77M | Sell |
14,160
-1,500
| -10% | -$182K | 0.26% | 91 |
|
|
2014
Q3 | $1.91M | Buy |
15,660
+564
| +4% | +$68.6K | 0.29% | 80 |
|
|
2014
Q2 | $1.78M | Buy |
15,096
+800
| +6% | +$94.2K | 0.28% | 88 |
|
|
2014
Q1 | $1.72M | Sell |
14,296
-1,299
| -8% | -$154K | 0.3% | 75 |
|
|
2013
Q4 | $1.74M | Sell |
15,595
-2,950
| -16% | -$293K | 0.29% | 73 |
|
|
2013
Q3 | $1.71M | Sell |
18,545
-1,740
| -9% | -$157K | 0.31% | 78 |
|
|
2013
Q2 | $1.72M | Buy |
+20,285
| New | +$1.69M | 0.32% | 72 |
|
Other funds holding TMO
VCM
Meiji Yasuda Life Insurance's TMO Position: Q1 2026 in Review
Meiji Yasuda Life Insurance held its Thermo Fisher Scientific (TMO) position steady in Q1 2026 at 5,068 shares worth $2.49M. The position accounts for 0.09% of the portfolio, ranked #52.
Meiji Yasuda Life Insurance first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $9.8M in Q3 2024. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Meiji Yasuda Life Insurance held 5,068 shares of Thermo Fisher Scientific worth $2.49M as of Q1 2026.
- Meiji Yasuda Life Insurance left its Thermo Fisher Scientific share count unchanged in Q1 2026.
- Thermo Fisher Scientific made up 0.09% of Meiji Yasuda Life Insurance's portfolio in Q1 2026, its #52 holding.
- Meiji Yasuda Life Insurance first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
- Meiji Yasuda Life Insurance's Thermo Fisher Scientific position peaked at $9.8M in Q3 2024.
- 2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Meiji Yasuda Life Insurance's 13F filing for Q1 2026, filed 12 May 2026.